Tyrosine-Sulfate Mimetics That Inhibit H1V-1 Entry Derived By A Structure Guided Approach, And Their Use As H1V-1 Therapeutics Read more about Tyrosine-Sulfate Mimetics That Inhibit H1V-1 Entry Derived By A Structure Guided Approach, And Their Use As H1V-1 Therapeutics US Application 61/532,635Filed on 2011-09-09
Treatment And Prevention Of Tuberculosis Via Drug-Mediated Manipulation Of The Eicosanoid Balance and Treatment and Prevention of Diseases Mediated By Microorganisms Via Drug-Mediated Manipulation of the Eicosanoid Balance Read more about Treatment And Prevention Of Tuberculosis Via Drug-Mediated Manipulation Of The Eicosanoid Balance and Treatment and Prevention of Diseases Mediated By Microorganisms Via Drug-Mediated Manipulation of the Eicosanoid Balance US Application 61/515,229Filed on 2011-08-04
VIRUS-LIKE PARTICLES AND METHODS OF USE Read more about VIRUS-LIKE PARTICLES AND METHODS OF USE US Application 61/501,012Filed on 2011-06-24
Prime-boost Vaccine Strategies Incorporating Lymphocytic Choriomeningitis Virus (LCMV) Vaccines To Protect Against Lentiviral Infection Read more about Prime-boost Vaccine Strategies Incorporating Lymphocytic Choriomeningitis Virus (LCMV) Vaccines To Protect Against Lentiviral Infection US Application 61/489,205Filed on 2011-05-23
Ubiquitin Fusions For Improving The Efficacy Of Cytosolic Acting Targeted Toxins Read more about Ubiquitin Fusions For Improving The Efficacy Of Cytosolic Acting Targeted Toxins US Application 61/473,450Filed on 2011-04-08
Plasmodial Surface Anion Channel Inhibitors For The Treatment of Malaria Read more about Plasmodial Surface Anion Channel Inhibitors For The Treatment of Malaria US Application 61/474,583Filed on 2011-04-12
Vaccines Directed Against Adenovirus Serotype 14 Read more about Vaccines Directed Against Adenovirus Serotype 14 US Application 61/013,201Filed on 2007-12-12
Novel HIV-1 Broadly Neutralizing Antibodies Read more about Novel HIV-1 Broadly Neutralizing Antibodies US Application 61/386,211Filed on 2010-09-24
HIV Neutralizing Antibodies Having Mutations In Constant Domain(FC) Read more about HIV Neutralizing Antibodies Having Mutations In Constant Domain(FC) US Application 61/439,678Filed on 2011-02-04
Recombinant MVA Viruses Expressing Clades A/G, B, And C Modified HIV env, Gag And Pol Genes; Recombinant MVA Expressing GM-CSF. Read more about Recombinant MVA Viruses Expressing Clades A/G, B, And C Modified HIV env, Gag And Pol Genes; Recombinant MVA Expressing GM-CSF. US Application 61/251,119Filed on 2009-10-13